Baird raised the firm’s price target on Cencora (COR) to $292 from $287 and keeps an Outperform rating on the shares. The firm said they delivered another solid report, guided favorably, and announced a very intriguing MSO deal in a new field for distributors; retina care specialists.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks